Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q2 2019 · 10-Q
Revenue—
Net Income-$3.95M-$3.95MN/M vs Q2 2018 EPS Diluted-$0.29-$0.29N/M vs Q2 2018 Operating Income-$3,982,451N/M Operating Cash Flowderived-$3,018,242N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end